MNKD Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $3.80

Kapitalisasi Pasar (MRQ) $1.18B

P/E (TTM) -29.2

EPS (TTM) $-0.13

Pendapatan (TTM) $394M

ROE (TTM) 71.4%

Rentang 52M $2–$7

MNKD Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 1

Tanggal ex-dividen	Pemecahan	Tipe
3 Maret 2017	1-for-5	Terbalik

Tentang MannKind Corporation - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.

MannKind Corporation was named after its founder, Alfred E. Mann.

History

Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).

The FDA approved Afrezza on June 27, 2014.

On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.

In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.

Products and product candidates

The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.

Leadership

Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.

In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.

Facilities

MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.

Baca selengkapnya Tampilkan lebih sedikit

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan591 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$349M

2016-12-31 → 2025-12-31

EPS$0.02

2016-12-31 → 2025-12-31

Arus Kas Bebas$14M

2018-12-31 → 2025-12-31

Margin bersih-11.1%

2017-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	MNKD	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-29.2rata-rata 5T ≈45.5	≈45.5	·	·
P/S (TTM)	3.0rata-rata 5T ≈9.1	≈9.1	21.2	Kurang nilai
P/B (MRQ)	-17.5rata-rata 5T ≈-14.7	≈-14.7	·	·
Harga / FCF (TTM)	-64.9rata-rata 5T ≈7.7	≈7.7	·	·
Harga / Arus Kas (TTM)	-146.2rata-rata 5T ≈27.0	≈27.0	·	·
Harga / Nilai Buku Berwujud (MRQ)	-16.3	·	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	MNKD	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	2.3%rata-rata 5T ≈-17.1%	≈-17.1%	-308.7%	Tingkat teratas
EBITDA Margin (Margin EBITDA)	11.1%rata-rata 5T ≈-17.1%	≈-17.1%	-308.7%	Tingkat teratas
Margin Sebelum Pajak (TTM)	-12.4%rata-rata 5T ≈-37.8%	≈-37.8%	·	·
Margin Laba Bersih (TTM)	-11.1%rata-rata 5T ≈-37.9%	≈-37.9%	-214.0%	Tingkat teratas
ROA (TTM)	-7.6%rata-rata 5T ≈-12.4%	≈-12.4%	-44.4%	Tingkat teratas
ROE (TTM)	71.4%rata-rata 5T ≈10.3%	≈10.3%	-11.7%	Sejajar
ROIC	-316.9%rata-rata 5T ≈-71.2%	≈-71.2%	-128.0%	Lemah

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	MNKD	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		1.7rata-rata 5T ≈3.3	≈3.3	10.6	Likuiditas rendah
Rasio Cepat (MRQ)		1.1rata-rata 5T ≈2.8	≈2.8	5.1	Likuiditas rendah

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	MNKD	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	22.2%rata-rata 5T ≈42.6%	≈42.6%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	51.8%rata-rata 5T ≈50.9%	≈50.9%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	39.9%	·	·	·
EPS YoY	-80.0%	·	·	·
Net Income YoY (Laba Bersih YoY)	-78.8%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	MNKD	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$0.02rata-rata 5T ≈$-0.12	≈$-0.12	·	·
Revenue / Share (Pendapatan / Saham)	$1.11rata-rata 5T ≈$0.81	≈$0.81	·	·
Cash Flow / Share (Arus Kas / Saham)	$0.06rata-rata 5T ≈$0.01	≈$0.01	·	·
Cash / Share (Kas / Saham)	$0.24rata-rata 5T ≈$0.41	≈$0.41	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	MNKD	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.6rata-rata 5T ≈0.5	≈0.5	0.3	Tingkat teratas
Inventory Turnover (Perputaran Persediaan)	0.8rata-rata 5T ≈1.2	≈1.2	·	·
Receivables Turnover (Perputaran Piutang)	13.9rata-rata 5T ≈14.7	≈14.7	·	·
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$590.5K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata -86.3%

Laporan Berikutnya Nov 03, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 12, 2026	$-0.06	$-0.00	—
31 Maret 2026	Mei 13, 2026	$-0.05	$-0.00	—
31 Des. 2025		$-0.05	$0.01	-440.1%
30 Sep. 2025		$0.07	$0.02	205.9%
30 Juni 2025		$0.00	$0.05	-100.0%
31 Maret 2025		$0.04	$0.04	-10.9%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 16

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$349M	$286M	$199M	$100M	$75M	$65M	$63M	$28M	$12M	$175M	$0	$0
Cost of Revenue	$27M	$17M	$21M	$16M	$17M	$15M	$20M	$19M	$17M	$17M	$65M	·
SG&A Expense	$144M	$94M	$94M	$91M	$32M	$25M	$75M	$80M	$75M	$47M	$41M	$79M
Operating Expenses	$88M	$77M	$63M	$57M	$39M	$25M	$108M	$104M	$120M	$107M	$345M	$180M
Operating Income	$39M	$73M	$9M	$-64M	$-47M	$-48M	$-45M	$-77M	$-108M	$67M	$-345M	$-180M
Interest Expense	·	·	$15M	$15M	$15M	·	·	·	·	·	$24M	$20M
Interest Income	$8M	$13M	$6M	$3M	$112.0K	$167.0K	$997.0K	$501.0K	$293.0K	$85.0K	$18.0K	$9.0K
Other Non-op	$-1M	$32.0K	$122.0K	$-102.0K	$-239.0K	$23.0K	$-926.0K	$-437.0K	$13.0K	$-597.0K	$1M	$2M
Pretax Income	$1M	$31M	$-10M	$-87M	$-81M	$-57M	$-52M	$-87M	$-117M	$126M	$-368M	$-198M
Income Tax	$-4M	$3M	$2M	$0	$0	$-218.0K	$0	$240.0K	$51.0K	$0	$0	$0
Net Income	$6M	$28M	$-12M	$-87M	$-81M	$-57M	$-52M	$-87M	$-117M	$126M	$-368M	$-198M
EPS (Basic)	$0.02	$0.10	$-0.04	$-0.34	$-0.32	$-0.26	·	$-0.60	$-1.13	$1.37	$-4.54	$-2.57
EPS (Diluted)	$0.02	$0.10	$-0.04	$-0.34	$-0.32	$-0.26	·	$-0.60	$-1.13	$1.36	$-4.54	$-2.57
Shares (Basic)	305,639,000	274,415,000	267,014,000	257,092,000	249,244,000	222,585,000	·	144,136,000	104,245,000	92,053,000	81,233,000	77,045,000
Shares (Diluted)	314,112,000	283,844,000	267,014,000	257,092,000	249,244,000	222,585,000	·	144,136,000	104,245,000	92,085,000	81,233,000	77,045,000
EBITDA	$39M	$73M	$9M	$-64M	$-47M	$-48M	$-45M	$-77M	$-106M	·	$-334M	$-170M

Neraca 28

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$75M	$46M	$238M	$70M	$124M	$67M	$30M	$71M	$44M	$23M	$59M	$121M
Short-term Investments	$96M	$151M	$57M	$101M	$80M	$0	$20M	·	·	·	·	·
Receivables	$38M	$12M	$15M	$17M	$5M	$4M	$4M	$4M	$3M	$302.0K	$23.0K	$50M
Inventory	$35M	$28M	$29M	$22M	$7M	$5M	$4M	$4M	$3M	$2M	·	$10M
Prepaid Expense	$47M	$31M	$35M	$25M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$20M
Current Assets	$292M	$268M	$373M	$235M	$219M	$79M	$61M	$82M	$57M	$77M	$77M	$201M
PP&E (Net)	$82M	$85M	$84M	$45M	$37M	$26M	$27M	$26M	$27M	$29M	$49M	$192M
PP&E (Gross)	$196M	$192M	$186M	$144M	$134M	$123M	$122M	$126M	$128M	$129M	$168M	$310M
Accum. Depreciation	$114M	$107M	$102M	$99M	$98M	$97M	$95M	$100M	$101M	$100M	$120M	$118M
Goodwill	$68M	$2M	$2M	$2M	·	·	·	·	·	·	·	·
Intangibles	$5M	$5M	$1M	$1M	·	·	·	·	·	·	·	·
Other Non-current Assets	$20M	$27M	$7M	$10M	$8M	$3M	$6M	$249.0K	$437.0K	$648.0K	$1M	$848.0K
Total Assets	$792M	$394M	$475M	$295M	$321M	$109M	$94M	$108M	$85M	$107M	$126M	$394M
Accounts Payable	$9M	$7M	$10M	$11M	$7M	$6M	$5M	$5M	$7M	$3M	$16M	$7M
Accrued Liabilities	$65M	$40M	$42M	$36M	$27M	$20M	$16M	$15M	$12M	$8M	$8M	$26M
Short-term Debt	·	·	·	·	·	·	$5M	·	·	·	·	·
Current Liabilities	$171M	$82M	$104M	$67M	$48M	$74M	$66M	$75M	$88M	$92M	$268M	$403M
Capital Leases	$11M	$12M	$4M	$5M	$1M	$1M	$3M	·	·	·	·	·
Other Non-current Liabilities	·	·	·	·	$5M	·	·	·	·	·	$15M	$12M
Total Liabilities	$843M	$473M	$721M	$546M	$531M	$289M	$284M	$283M	$299M	$291M	$477M	$468M
Long-term Debt	$355M	$36M	$269M	$273M	$281M	$122M	$119M	$102M	$157M	·	·	·
Total Debt	·	·	·	·	·	·	$5M	·	·	·	·	·
Common Stock	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$1M	$957.0K	$4M	$4M
Retained Earnings	$-3.20B	$-3.20B	$-3.23B	$-3.22B	$-3.13B	$-3.05B	$-2.99B	$-2.94B	$-2.85B	$-2.74B	$-2.86B	$-2.49B
AOCI	$115.0K	$1M	·	·	·	·	$-19.0K	$-19.0K	$-18.0K	$-24.0K	$-20.0K	$-14.0K
Stockholders' Equity	$-51M	$-79M	$-246M	$-251M	$-209M	$-180M	$-191M	$-175M	$-215M	$-184M	$-350M	$-74M
Liabilities + Equity	$792M	$394M	$475M	$295M	$321M	$109M	$94M	$108M	$85M	$107M	$126M	$394M
Shares Outstanding	307,832,587	302,959,782	270,034,495	263,793,305	251,477,562	242,117,089	211,787,573	187,029,967	119,053,414	95,680,831	85,734,188	406,059,089

Arus Kas 18

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$12M	$7M	$5M	$3M	$2M	$2M	$972.0K	$3M	$2M	$2M	$11M	$10M
Stock-based Comp	$24M	$21M	$18M	$13M	$12M	$7M	$6M	$7M	$5M	$5M	$9M	$49M
Deferred Tax	$-19M	$4M	$7M	$-10M	$-20M	$-5M	$-5M	$-11M	$-260M	$48M	$-80M	$-66M
Amort. of Intangibles	$4M	·	·	·	·	·	·	·	·	·	·	·
Restructuring	·	·	·	·	·	·	·	·	·	$2M	$6M	$2M
Other Non-cash	·	·	·	·	·	·	·	·	$306M	·	$291M	$144M
Operating Cash Flow	$18M	$43M	$34M	$-81M	$-62M	$-28M	$-88M	$-38M	$-65M	$-78M	$-57M	$4M
CapEx	$5M	$10M	$42M	$8M	$11M	$801.0K	$3M	$354.0K	·	$1M	$10M	$24M
Investing Cash Flow	$-305M	$-97M	$-2M	$5M	$-152M	$15M	$-23M	$-234.0K	$17M	$-1M	·	·
Debt Issued	·	·	·	·	·	$5M	·	·	·	·	·	$20M
Net Debt Issued	·	·	·	·	·	$5M	·	·	·	·	·	·
Stock Issued	·	·	·	·	·	·	·	·	$564.0K	$893.0K	$28M	·
Net Stock Activity	·	·	·	·	·	·	·	·	$564.0K	·	$28M	·
Financing Cash Flow	$315M	$-137M	$137M	$21M	$270M	$50M	$70M	$61M	$74M	$43M	·	·
Net Change in Cash	$29M	$-191M	$169M	$-54M	$57M	$37M	$-41M	$23M	$25M	$-36M	$-62M	$50M
Taxes Paid	$2M	$4M	·	·	·	·	·	·	·	·	·	·
Free Cash Flow	$14M	$33M	$-8M	$-88M	$-73M	$-29M	$-91M	$-38M	·	·	$-68M	$-20M
Levered FCF	·	·	$-26M	$-98M	·	·	·	·	·	·	$-92M	·

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	11.1%	25.4%	4.4%	-64.3%	-62.3%	-73.6%	-70.8%	-274.9%	-921.1%	·	·	·
Net Margin	1.7%	9.7%	-6.0%	-87.6%	-107.3%	-87.9%	-82.3%	-312.2%	-999.0%	·	·	·
Pretax Margin	0.40%	10.7%	-5.2%	-87.6%	-107.3%	-88.2%	-82.3%	-311.3%	-998.6%	·	·	·
EBITDA Margin	11.1%	25.4%	4.4%	-64.3%	-62.3%	-73.6%	-70.8%	-274.9%	-905.8%	·	·	·
ROA	0.99%	6.3%	-3.1%	-28.4%	-37.7%	-56.6%	-51.5%	-90.5%	-122.4%	·	-141.5%	-60.8%
ROE	-11.1%	-19.1%	4.8%	35.8%	41.1%	31.2%	27.7%	45.7%	58.9%	·	173.8%	379.7%
ROIC	-316.9%	-83.2%	-4.1%	25.6%	22.5%	26.5%	24.0%	43.9%	50.4%	·	98.4%	·

Likuiditas & Solvabilitas 4

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.7	3.3	3.6	3.5	4.5	1.1	0.9	1.1	0.7	·	0.3	0.5
Quick Ratio	1.2	2.6	3.0	2.8	4.3	1.0	0.8	1.0	0.5	·	0.2	0.4
Debt / Equity	·	·	·	·	·	·	-0.0	·	·	·	·	·
Interest Coverage	·	·	0.6	-6.7	·	·	·	·	·	·	-14.3	-8.8

Efisiensi 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.6	0.7	0.5	0.3	0.4	0.6	0.6	0.3	0.1	·	0.0	·
Inventory Turnover	0.8	0.6	0.8	1.1	2.8	3.3	5.2	6.2	6.9	·	·	·
Receivables Turnover	13.9	21.4	12.6	9.3	16.4	16.9	16.7	8.2	7.6	·	0.0	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$-0.17	$-0.26	$-0.91	$-0.95	$-0.83	$-0.75	$-0.90	$-0.94	$-1.80	·	$-0.82	$-0.18
Revenue / Share	$1.11	$1.01	$0.75	$0.39	·	·	·	$0.19	$0.11	·	·	·
Cash Flow / Share	$0.06	$0.15	$0.13	$-0.31	·	·	·	$-0.26	$-0.62	·	·	·
Cash / Share	$0.24	$0.15	$0.88	$0.26	$0.49	$0.28	$0.14	$0.38	$0.37	·	$0.14	$0.30
EPS (TTM)	$0.02	$0.10	$-0.04	$-0.34	$-0.32	$-0.26	$-0.63	$-0.60	$-1.13	$1.36	$-4.54	$-2.57

Tingkat Pertumbuhan 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	22.2%	43.5%	99.4%	32.2%	15.8%	·	·	·	·	·	·	·
Revenue CAGR 3Y	51.8%	55.8%	45.1%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	39.9%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-80.0%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-78.8%	·	·	·	·	·	·	·	·	·	·	·

Valuasi (TTM) 13

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$349M	$286M	$199M	$100M	$75M	$65M	$63M	$28M	$12M	$175M	$0	$0
Net Income TTM	$6M	$28M	$-12M	$-87M	$-81M	$-57M	$-52M	$-87M	$-117M	$126M	$-368M	$-198M
Market Cap	$1.75B	$1.95B	$983M	$1.39B	$1.10B	$758M	$273M	$198M	$276M	·	$3.11B	$10.60B
Enterprise Value	·	·	·	·	·	·	$228M	·	·	·	·	·
P/E	283.5	64.3	-91.0	-15.5	-13.7	-12.0	-2.0	-1.8	-2.1	2.4	-1.6	-10.2
P/S	5.0	6.8	4.9	13.9	14.6	11.6	4.3	7.1	23.5	·	·	·
P/B	-34.2	-24.7	-4.0	-5.5	-5.2	-4.2	-1.4	-1.1	-1.3	·	-8.9	-143.7
P / Cash Flow	95.6	45.8	28.8	-17.2	-17.8	-26.9	-3.1	-5.3	-4.3	·	-54.3	2593.8
P / FCF	127.5	59.4	-117.8	-15.7	-15.0	-26.2	-3.0	-5.2	·	·	-46.0	-529.6
EV / EBITDA	·	·	·	·	·	·	-5.1	·	·	·	·	·
EV / FCF	·	·	·	·	·	·	-2.5	·	·	·	·	·
EV / Revenue	·	·	·	·	·	·	3.6	·	·	·	·	·
Earnings Yield	0.35%	1.6%	-1.1%	-6.5%	-7.3%	-8.3%	-48.8%	-56.6%	-48.7%	42.5%	-62.6%	-9.8%

Laporan Laba Rugi 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$109M	$90M	$112M	$82M	$77M	$78M	$77M	$70M	$72M	$66M	$58M	$51M	$49M	$41M	$36M	$33M
Cost of Revenue	$14M	$8M	$14M	$4M	$5M	$4M	$5M	$3M	$6M	$4M	$6M	$4M	$5M	$6M	$4M	$5M
SG&A Expense	$58M	$54M	$58M	$29M	$32M	$25M	$24M	$24M	$24M	$22M	$61M	$11M	$12M	$11M	$64M	$9M
Operating Expenses	$30M	$92M	$-103M	$63M	$21M	$56M	$-86M	$57M	$56M	$50M	$18M	$14M	$14M	$16M	$16M	$17M
Operating Income	$-350.0K	$-2M	$-8M	$19M	$5M	$22M	$26M	$13M	$17M	$17M	$8M	$5M	$2M	$-6M	$-13M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	$6M	$3M	·	$3M	$7M	$3M	·	$3M
Interest Income	$1M	$1M	$2M	$3M	$2M	$2M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$1M	$957.0K	$663.0K
Other Non-op	$-5M	$-3M	$23M	$-11M	$-4M	$-9M	$24M	$110.0K	$-18M	$-6M	$-164.0K	$318.0K	$-143.0K	$111.0K	$105.0K	$-207.0K
Pretax Income	$-19M	$-16M	$-21M	$8M	$940.0K	$14M	$8M	$13M	$-2M	$11M	$3M	$2M	$-5M	$-10M	$-18M	$-14M
Income Tax	$-106.0K	$253.0K	$-5M	$-204.0K	$272.0K	$459.0K	$1M	$1M	$323.0K	$264.0K	$2M	$0	$0	$0	·	$0
Net Income	$-19M	$-17M	$-16M	$8M	$668.0K	$13M	$7M	$12M	$-2M	$11M	$1M	$2M	$-5M	$-10M	$-18M	$-14M
EPS (Basic)	$-0.06	$-0.05	$-0.05	$0.03	$0.00	$0.04	$0.03	$0.04	$-0.01	$0.04	$0.01	$0.01	$-0.02	$-0.04	$-0.07	$-0.06
EPS (Diluted)	$-0.06	$-0.05	$-0.05	$0.03	$0.00	$0.04	$0.03	$0.04	$-0.01	$0.04	$0.01	$0.01	$-0.02	$-0.04	$-0.07	$-0.06
Shares (Basic)	309,191,000	308,267,000	·	306,806,000	304,954,000	303,481,000	·	274,998,000	273,056,000	270,356,000	·	268,732,000	265,626,000	263,969,000	·	259,300,000
Shares (Diluted)	309,191,000	308,267,000	·	311,638,000	311,484,000	320,897,000	·	284,693,000	273,056,000	324,733,000	·	323,770,000	265,626,000	263,969,000	·	259,300,000
EBITDA	·	$-2M	·	$19M	$5M	$22M	·	$13M	$17M	$17M	·	$5M	$2M	$-6M	·	$-10M

Neraca 25

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$53M	$53M	$75M	$127M	$57M	$47M	$46M	$62M	$97M	$193M	·	$83M	$86M	$86M	·	$54M
Short-term Investments	$58M	$81M	$96M	$133M	$122M	$134M	$151M	$189M	$151M	$107M	·	$58M	$58M	$80M	·	$111M
Receivables	$43M	$28M	$38M	$17M	$27M	$29M	$12M	$18M	$23M	$20M	·	$22M	$28M	$20M	·	$23M
Inventory	$44M	$49M	$35M	$27M	$28M	$29M	$28M	$27M	$25M	$26M	·	$27M	$25M	$22M	·	$18M
Prepaid Expense	$47M	$40M	$47M	$54M	$44M	$34M	$31M	$31M	$30M	$36M	·	$36M	$33M	$15M	·	$12M
Current Assets	$246M	$251M	$292M	$359M	$279M	$274M	$268M	$328M	$326M	$383M	·	$226M	$230M	$223M	·	$218M
PP&E (Net)	$85M	$83M	$82M	$83M	$83M	$84M	$85M	$85M	$85M	$84M	·	$80M	$70M	$55M	·	$41M
PP&E (Gross)	$203M	$198M	$196M	$195M	$194M	$192M	$192M	$192M	$190M	$186M	·	$182M	$170M	$154M	·	$140M
Accum. Depreciation	$118M	$116M	$114M	$113M	$111M	$109M	$107M	$107M	$105M	$103M	·	$101M	$100M	$100M	·	$99M
Goodwill	$68M	$68M	$68M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$3M
Intangibles	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$1M	$1M	·	$1M	$1M	$1M	·	$1M
Other Non-current Assets	$17M	$22M	$20M	$19M	$20M	$28M	$27M	$26M	$16M	$7M	·	$8M	$8M	$16M	·	$17M
Total Assets	$732M	$744M	$792M	$495M	$412M	$410M	$394M	$464M	$444M	$481M	·	$320M	$313M	$298M	·	$294M
Accounts Payable	$11M	$16M	$9M	$7M	$10M	$5M	$7M	$6M	$10M	$7M	·	$17M	$17M	$14M	·	$10M
Accrued Liabilities	$61M	$59M	$65M	$31M	$31M	$40M	$40M	$37M	$41M	$42M	·	$32M	$37M	$33M	·	$30M
Current Liabilities	$143M	$135M	$171M	$109M	$112M	$116M	$82M	$72M	$80M	$100M	·	$96M	$97M	$82M	·	$60M
Capital Leases	$10M	$10M	$11M	$10M	$11M	$11M	$12M	$12M	$3M	$4M	·	$4M	$5M	$5M	·	$6M
Total Liabilities	$800M	$804M	$843M	$539M	$467M	$469M	$473M	$674M	$670M	$711M	·	$572M	$574M	$554M	·	$532M
Long-term Debt	$319M	$319M	$355M	$110M	$36M	$36M	$36M	$228M	$228M	$264M	·	$273M	$274M	$274M	·	$273M
Common Stock	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	·	$3M	$3M	$3M	·	$3M
Retained Earnings	$-3.23B	$-3.21B	$-3.20B	$-3.18B	$-3.19B	$-3.19B	$-3.20B	$-3.21B	$-3.22B	$-3.22B	·	$-3.23B	$-3.23B	$-3.23B	·	$-3.20B
AOCI	$-19.0K	$-4.0K	$115.0K	$137.0K	$1M	$1M	$1M	$588.0K	·	·	·	$443.0K	$443.0K	·	·	$-1M
Stockholders' Equity	$-67M	$-59M	$-51M	$-45M	$-55M	$-59M	$-79M	$-210M	$-226M	$-230M	$-246M	$-252M	$-260M	$-255M	$-251M	$-238M
Liabilities + Equity	$732M	$744M	$792M	$495M	$412M	$410M	$394M	$464M	$444M	$481M	·	$320M	$313M	$298M	·	$294M
Shares Outstanding	309,911,682	308,907,331	307,832,587	307,027,189	306,332,133	303,918,969	302,959,782	275,775,038	274,467,247	270,801,781	·	269,543,539	268,235,145	264,278,760	·	263,156,165

Arus Kas 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$6M	$6M	$6M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$-427.0K
Stock-based Comp	$10M	$6M	$7M	$4M	$8M	$5M	$6M	$5M	$6M	$4M	$4M	$5M	$6M	$4M	$3M	$4M
Amort. of Intangibles	$4M	$4M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-18M	$-5M	$-8M	$24M	$9M	$-6M	$23M	$9M	$4M	$7M	$22M	$9M	$3M	$1M	$-2M	$-28M
CapEx	$5M	$2M	$2M	$1M	$1M	$330.0K	$3M	$1M	$3M	$2M	$6M	$11M	$17M	$8M	$5M	$271.0K
Investing Cash Flow	$18M	$19M	$-292M	$-25M	$6M	$6M	$48M	$-41M	$-55M	$-48M	$-8M	$-12M	$4M	$14M	$15M	$27M
Financing Cash Flow	$559.0K	$-35M	$247M	$72M	$-6M	$1M	$-87M	$-2M	$-45M	$-3M	$142M	$-283.0K	$-6M	$1M	$3M	$20M
Net Change in Cash	$97.0K	$-22M	$-53M	$70M	$10M	$975.0K	$-16M	$-34M	$-96M	$-45M	$155M	$-3M	$315.0K	$16M	$15M	$19M
Taxes Paid	$753.0K	$63.0K	$549.0K	$80.0K	$869.0K	$207.0K	$2M	$236.0K	·	·	·	·	·	·	·	·
Free Cash Flow	·	$-7M	·	·	·	$-7M	·	·	·	$4M	·	·	·	$-7M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$2M	·	·	·	$-10M	·	·

Profitabilitas 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	·	-1.8%	·	23.0%	6.9%	28.4%	·	18.2%	22.9%	25.2%	·	9.9%	3.5%	-14.8%	·	-29.3%
Net Margin	·	-18.4%	·	9.7%	0.87%	16.8%	·	16.5%	-2.8%	16.0%	·	3.4%	-10.8%	-24.1%	·	-44.0%
Pretax Margin	·	-18.1%	·	9.5%	1.2%	17.4%	·	18.4%	-2.3%	16.4%	·	3.4%	-10.8%	-24.1%	·	-44.0%
EBITDA Margin	·	-1.8%	·	23.0%	6.9%	28.4%	·	18.2%	22.9%	25.2%	·	9.9%	3.5%	-14.8%	·	-29.3%
ROA	·	-2.9%	·	1.7%	0.16%	2.9%	·	2.9%	-0.53%	2.7%	·	0.56%	-1.8%	-3.2%	·	-5.4%
ROE	·	28.2%	·	-6.3%	-0.48%	-9.1%	·	-5.0%	0.83%	-4.4%	·	-0.70%	2.1%	4.0%	·	6.8%
ROIC	·	2.9%	·	-43.5%	-6.8%	-36.8%	·	-5.5%	-8.8%	-7.1%	·	-2.0%	-0.66%	2.4%	·	·

Likuiditas & Solvabilitas 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	·	1.9	·	3.3	2.5	2.4	·	4.5	4.1	3.8	·	2.3	2.4	2.7	·	3.7
Quick Ratio	·	1.2	·	2.5	1.8	1.8	·	3.7	3.4	3.2	·	1.7	1.8	2.3	·	3.2
Interest Coverage	·	·	·	·	·	·	·	·	2.7	6.5	·	1.8	0.3	-2.5	·	·

Efisiensi 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	·	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.1
Inventory Turnover	·	0.2	·	0.2	0.2	0.1	·	0.1	0.2	0.2	·	0.2	0.2	0.4	·	0.4
Receivables Turnover	·	3.2	·	4.6	3.0	3.2	·	3.5	2.8	3.3	·	2.3	2.3	2.8	·	2.0

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$-0.19	·	$-0.15	$-0.18	$-0.19	·	$-0.76	$-0.82	$-0.85	·	$-0.93	$-0.97	$-0.97	·	$-0.90
Revenue / Share	·	$0.29	·	$0.26	$0.25	$0.24	·	$0.25	$0.27	$0.20	·	$0.16	$0.18	$0.15	·	$0.13
Cash Flow / Share	·	$-0.02	·	·	·	$-0.02	·	·	·	$0.02	·	·	·	$0.00	·	·
Cash / Share	·	$0.17	·	$0.41	$0.19	$0.16	·	$0.23	$0.35	$0.71	·	$0.31	$0.32	$0.32	·	$0.21
EPS (TTM)	$-0.08	$-0.07	·	$0.10	$0.11	$0.10	·	$0.08	$0.05	$0.04	·	$-0.12	$-0.19	$-0.28	·	$-0.38

Valuasi (TTM) 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$358M	$361M	·	$314M	$302M	$298M	·	$267M	$248M	$225M	·	$177M	$158M	$128M	·	$76M
Net Income TTM	$-27M	$-24M	·	$29M	$33M	$30M	·	$22M	$12M	$8M	·	$-31M	$-47M	$-71M	·	$-98M
Market Cap	·	$757M	·	$1.65B	$1.15B	$1.53B	·	$1.73B	$1.43B	$1.23B	·	$1.11B	$1.09B	$1.08B	·	$813M
P/E	-53.2	-35.0	·	53.7	34.0	50.3	·	78.6	104.4	113.2	·	-34.4	-21.4	-14.6	·	-8.1
P/S	·	2.1	·	5.3	3.8	5.1	·	6.5	5.8	5.5	·	6.3	6.9	8.4	·	10.7
P/B	·	-12.8	·	-37.0	-20.8	-26.1	·	-8.3	-6.3	-5.3	·	-4.4	-4.2	-4.2	·	-3.4
P / Cash Flow	·	-141.1	·	·	·	-239.7	·	·	·	183.0	·	·	·	937.3	·	·
Earnings Yield	-1.9%	-2.9%	·	1.9%	2.9%	2.0%	·	1.3%	0.96%	0.88%	·	-2.9%	-4.7%	-6.8%	·	-12.3%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$349M	$286M	$199M	$100M	$75M
Margin Operasi %	11.1%	25.4%	4.4%	-64.3%	-62.3%
Laba Bersih	$6M	$28M	$-12M	$-87M	$-81M
EPS Dilusian	$0.02	$0.10	$-0.04	$-0.34	$-0.32

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rasio Lancar	1.7	3.3	3.6	3.5	4.5
Rasio Cepat	1.2	2.6	3.0	2.8	4.3

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$14M	$33M	$-8M	$-88M	$-73M

Pemilik institusional (13F) 271 pengaju · $883.4M total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 271

Nilai yang dipegang $883.4M

Posisi baru 51

Posisi yang keluar 39

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
51 (0 vs Kuartal sebelumnya)	39 (-8 vs Kuartal sebelumnya)	98 (+12 vs Kuartal sebelumnya)	63 (-7 vs Kuartal sebelumnya)	+1.9M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
BlackRock, Inc.	$136.887.530	32.133.223	15,50%	Saham
VANGUARD GROUP INC	$101.384.549	17.880.873	11,48%	Saham
Rubric Capital Management LP	$76.680.000	18.000.000	8,68%	Saham
STATE STREET CORP	$68.901.423	16.174.043	7,80%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$56.101.610	13.169.392	6,35%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$33.861.886	7.947.203	3,83%	Saham
WELLINGTON MANAGEMENT GROUP LLP	$33.418.878	7.844.807	3,78%	Saham
Frazier Life Sciences Management, L.P.	$28.116.000	6.600.000	3,18%	Saham
Deep Track Capital, LP	$25.560.000	6.000.000	2,89%	Saham
180 WEALTH ADVISORS, LLC	$21.126.835	4.959.351	2,39%	Saham
FMR LLC	$17.470.455	4.101.046	1,98%	Saham
TSP Capital Management Group, LLC	$16.923.596	3.972.675	1,92%	Saham
AQR CAPITAL MANAGEMENT LLC	$16.225.589	3.808.824	1,84%	Saham
MORGAN STANLEY	$14.802.946	3.474.870	1,68%	Saham
BRAIDWELL LP	$14.732.908	3.458.429	1,67%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$12.789.240	3.002.169	1,45%	Saham
NORTHERN TRUST CORP	$12.299.856	2.887.290	1,39%	Saham
UBS Group AG	$12.295.344	2.886.231	1,39%	Saham
TWO SIGMA INVESTMENTS, LP	$11.475.213	2.693.712	1,30%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$11.070.577	2.598.727	1,25%	Saham
BANK OF AMERICA CORP /DE/	$10.074.356	2.364.872	1,14%	Saham
VANGUARD FIDUCIARY TRUST CO	$9.358.279	2.196.779	1,06%	Saham
GOLDMAN SACHS GROUP INC	$9.178.165	2.154.499	1,04%	Saham
WELLS FARGO & COMPANY/MN	$6.289.519	1.476.413	0,71%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$5.030.221	1.180.803	0,57%	Saham
DIMENSIONAL FUND ADVISORS LP	$4.661.185	1.094.192	0,53%	Saham
Caption Management, LLC	$4.260.000	1.000.000	0,48%	Opsi jual
Bank of New York Mellon Corp	$3.827.454	898.463	0,43%	Saham
CITADEL ADVISORS LLC	$3.818.068	896.260	0,43%	Saham
J. Goldman & Co LP	$3.478.669	816.589	0,39%	Saham
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$3.019.973	1.232.642	0,34%	Saham
SCOPIA CAPITAL MANAGEMENT LP	$2.960.534	694.961	0,34%	Saham
Balyasny Asset Management L.P.	$2.914.296	684.107	0,33%	Saham
TWO SIGMA ADVISERS, LP	$2.897.166	510.964	0,33%	Saham
VICTORY CAPITAL MANAGEMENT INC	$2.771.407	650.565	0,31%	Saham
Nuveen, LLC	$2.708.218	635.732	0,31%	Saham
Swiss National Bank	$2.502.324	587.400	0,28%	Saham
STATE OF WISCONSIN INVESTMENT BOARD	$2.177.052	511.045	0,25%	Saham
JACOBS LEVY EQUITY MANAGEMENT, INC	$2.106.540	494.493	0,24%	Saham
1492 Capital Management LLC	$2.052.136	481.722	0,23%	Saham
Mariner, LLC	$2.020.189	474.236	0,23%	Saham
MILLENNIUM MANAGEMENT LLC	$1.836.597	431.126	0,21%	Saham
Schonfeld Strategic Advisors LLC	$1.774.216	416.483	0,20%	Saham
Squarepoint Ops LLC	$1.759.644	413.062	0,20%	Saham
Jefferies Financial Group Inc.	$1.694.202	397.700	0,19%	Saham
ExodusPoint Capital Management, LP	$1.666.261	391.141	0,19%	Saham
JANE STREET GROUP, LLC	$1.658.418	389.300	0,19%	Opsi beli
PRINCIPAL FINANCIAL GROUP INC	$1.629.561	382.526	0,18%	Saham
Man Group plc	$1.624.023	381.226	0,18%	Saham
RHUMBLINE ADVISERS	$1.604.647	376.681	0,18%	Saham

Tampilkan semua 271 pemilik institusional →

Aktivis & pemilik 5%+ 2 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 pengajuan	10 Juli 2012	·	Pengajuan awal	Investasi pasif	SEC
Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan	31 Jan. 2006	·	Pengajuan awal	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 43 orang dalam · 27 pejabat · 19 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Beli 12m	Jual 12m	Bersih 12m
Michael Castagna	Chief Executive Officer	15 Juli 2026 M	2.433.779	1	4	$-990.292
Hakan Edstrom	President & CEO	27 Agu 2015 A	1.114.340	0	0	$0
Christopher B Prentiss	Chief Financial Officer	15 Juli 2026 F	318.668	0	0	$0
Juergen Martens	Corporate VP and COO	27 Agu 2015 A	106.539	0	0	$0
Dominic Marasco	Pres, Endocrine Business Unit	15 Juli 2026 F	343.398	0	0	$0
Sanjay R Singh	EVP Technical Operations	15 Juli 2026 M	478.966	0	1	$-94.448
Stuart A Tross	Chief People & Workpl Officer	15 Juli 2026 M	1.058.142	0	1	$-297.548
David Thomson	EVP Genl Counsel & Secretary	15 Juli 2026 M	797.554	0	3	$-930.755
Ajay Ahuja	Chief Medical Officer	23 Maret 2026 A	318.200	0	0	$0
Lauren M Sabella	EVP Operations	15 Juli 2025 F	349.841	0	0	$0
Burkhard Blank	EVP Chief Medical Officer	15 Juli 2025 F	460.791	0	0	$0
Joseph Kocinsky	Chief Technology Officer	27 Agu 2022 F	745.233	0	0	$0
Alejandro Galindo	EVP Endocrine Business Unit	28 Feb. 2022 A	576.690	0	0	$0
Rosabel Realica Alinaya	VP, IR & Treasury	27 Agu 2020 A	167.119	0	0	$0
David M Kendall	Chief Medical Officer	31 Juli 2020 P	41.059	0	0	$0
Patrick Mccauley	Chief Commercial Officer	25 Feb. 2020 A	83.972	0	0	$0
Courtney Barton	Chief Compl & Privacy Officer	31 Juli 2019 P	29.584	0	0	$0
Elizabeth Garrett Ingram	Chief Marketing Officer	14 Mei 2019 A	43.012	0	0	$0
Raymond W. Urbanski	Corp VP, CMO	10 Agu 2017 S	2.924	0	0	$0
Linda A Adreveno	Sr. VP, HR	18 Feb. 2016 A	92.200	0	0	$0
Alfred E Mann	Executive Chairman	22 Agu 2015 F	1.005.990	0	0	$0
Diane Palumbo	Vice President, Human Resource	23 Feb. 2015 F	50.624	0	0	$0
Peter C Richardson	Chief Scientific Officer	3 Maret 2012 F	133.611	0	0	$0
Richard L Anderson	Corporate VP	16 Nov. 2008 F	204.401	0	0	$0
John R. Riesenberger	VP & Chief Commercial Officer	13 Agu 2008 A	14.650	0	0	$0
Dan Burns	VP & President, MKBP	8 Des. 2006 A	14.800	0	0	$0
Wendell W Cheatham	VP, Medical & Reg Affairs	19 Agu 2004 A	300	0	0	$0
Steven B. Binder	Direktur	25 Sep. 2026 S	713.258	0	5	$-683.703
Sabrina Kay	Direktur	20 Mei 2026 A	265.600	0	0	$0
Jennifer Grancio	Direktur	20 Mei 2026 A	244.815	0	0	$0
James Samuel Shannon	Direktur	20 Mei 2026 A	64.635	0	0	$0
Michael A Friedman	Direktur	20 Mei 2026 A	47.500	0	0	$0
Anthony C Hooper	Direktur	20 Mei 2026 A	236.153	0	0	$0
Christine Mundkur	Direktur	20 Mei 2026 A	254.493	0	0	$0
Ronald J Consiglio	Direktur	20 Mei 2026 A	132.342	0	0	$0
Kent Kresa	Direktur	15 Mei 2024 A	274.541	0	0	$0
Henry L Nordhoff	Direktur	14 Mei 2019 A	103.426	0	0	$0
David Maccallum	Direktur	16 Mei 2018 A	114.790	0	0	$0
Matthew J Pfeffer	Direktur	28 Agu 2017 F	81.961	0	0	$0
Abraham E Cohen	Direktur	17 Agu 2012 S	56.424	0	0	$0
Heather Hay Murren	Direktur	13 Agu 2008 A	10.100	0	0	$0
Kathleen Connell	Direktur	25 Mei 2006 A	·	0	0	$0
Llew Keltner	Direktur	25 Mei 2006 A	·	0	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 29 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
JSMD · Janus Detroit Street Trust	0,62%	1.678.187 NS	31 Juli 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,52%	29.891 SH	2 Okt. 2026	Harian
JSML · Janus Detroit Street Trust	0,49%	450.643 NS	31 Juli 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0,37%	1.212.660 NS	31 Juli 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,23%	289.432 NS	31 Juli 2026	N-PORT
FYX · First Trust Exchange-Traded AlphaDE…	0,12%	409.547 NS	31 Juli 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,09%	22.737 SH	2 Okt. 2026	Harian
IBB · iShares Trust	0,08%	2.264.902 SH	11 Sep. 2026	Harian
VTWG · VANGUARD SCOTTSDALE FUNDS	0,08%	330.117 SH	19 Agu 2026	Harian
IWO · iShares Trust	0,08%	2.877.921 SH	11 Sep. 2026	Harian
FAD · First Trust Exchange-Traded AlphaDE…	0,07%	109.855 NS	31 Juli 2026	N-PORT
PWS · Pacer Funds Trust	0,06%	3.954 NS	31 Juli 2026	N-PORT
ESML · iShares Trust	0,05%	333.357 SH	11 Sep. 2026	Harian
VTWO · VANGUARD SCOTTSDALE FUNDS	0,04%	1.771.496 SH	19 Agu 2026	Harian
RSSL · Global X Funds	0,04%	147.059 NS	31 Juli 2026	N-PORT
ISCG · iShares Trust	0,04%	96.772 SH	11 Sep. 2026	Harian
IWM · iShares Trust	0,04%	7.845.946 SH	11 Sep. 2026	Harian
VHT · VANGUARD WORLD FUND	0,02%	874.372 SH	19 Agu 2026	Harian
FHLC · FIDELITY COVINGTON TRUST	0,02%	139.696 NS	31 Juli 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	3.543.398 SH	19 Agu 2026	Harian
WSML · iShares Trust	0,01%	16.637 SH	11 Sep. 2026	Harian
TILT · FlexShares Trust	0,00%	23.700 NS	31 Juli 2026	N-PORT
ITOT · iShares Trust	0,00%	465.405 SH	11 Sep. 2026	Harian
IWV · iShares Trust	0,00%	84.120 SH	10 Sep. 2026	Harian
DFAC · Dimensional ETF Trust	0,00%	58.407 NS	31 Juli 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	11.291 NS	31 Juli 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	9.327.332 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	26.184 SH	19 Agu 2026	Harian
ISCB · iShares Trust	·	13.557 SH	11 Sep. 2026	Harian

MNKD Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 14 analis BELI

Target median $7.50 +97,4%

4 28,6% Beli Kuat

8 57,1% Beli

2 14,3% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

8 analis · 2026-09-28

Target rata-rata $7.97 +109,7%

← Di bawah semua target Harga saat ini $3.80

Rendah$4.75 Rata-rata$7.97 Tinggi$13.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
MNKD	$1.75B	283.5	22.2%	1.7%	-11.1%	·
ORIC	$806M	-5.6	·	·	-36.5%	·
DMRA	·	·	38.3%	-17981.1%	-167.0%	·
REPL	$633M	-2.3	·	·	-146.2%	·
TRAX	·	·	·	·	·	·
BCAX	$953M	-6.7	·	·	-33.0%	·
VOR	$506M	-0.2	·	·	83.4%	·
MGTX	$645M	-5.6	144.6%	-140.3%	8062.2%	·
JANX	$833M	-7.5	-5.5%	-1136.2%	-11.7%	·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story” Yahoo Finance · 3 bulan, 3 minggu lalu MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy Yahoo Finance · 3 bulan, 3 minggu lalu H.C. Wainwright dan Wells Fargo Menaikkan Target Harga MannKind (MNKD) Yahoo Finance · 4 bulan, 3 minggu lalu Apakah MannKind Corporation (MNKD) Salah Satu Saham Penny Populer di Robinhood untuk Dibeli? Yahoo Finance · 6 bulan lalu

Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan

25

BOUNCE_UP Stop out Des 23

risiko 1 imbalan 2,00

masuk $5.89 R:R 2,00

Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

MNKD MannKind Corporation - Common Stock